VG-1

For the type of steel, see VG-1 (steel).

VG-1 is a B cell line which was derived from primary effusion lymphoma (PEL) (Lu et al. 2009). It was first established in 2000 by David T. Scadden’s group at Massachusetts General Hospital. It is infected with Kaposi's sarcoma-associated herpesvirus (KSHV), but negative with Epstein-Barr virus (EBV) (Brander et al. 2000).

References

Brander, C.; Suscovich, T.; Lee, Y.; Nguyen, P.T.; O'Connor, P.; Seebach, J.; Jones, N.G.; van Gorder, M.; Walker, B.D.; Scadden, D.T. (2000), "Impaired CTL Recognition of Cells Latently Infected with Kaposi's Sarcoma-Associated Herpes Virus", J Immunol 165, pp. 2077–83, retrieved 17 October 2013 

Lu, P.; Yang, C.; Guasparri, I.; Harrington, W.; Wang, Y.L.; Cesarman, E. (2009), "Early Events of B-cell Receptor Signaling are not Essential for the Proliferation and Viability of AIDS-Related Lymphoma", Leukemia 23 (4), pp. 807–10 

External links

This article is issued from Wikipedia - version of the Monday, February 15, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.